18 dec 2022 contains a list of 1250 peer-reviewed case reports studying the relationship between Covid-19 vaccines and adverse side effects or death. This document contains only those case studies (240) that show causality or strong association between Covid-19 vaccines and injury or death. Causative or associative language can be found in either the extract, body, discussion or conclusion of the following reports. (Source:

Innate Immune Suppression by SARS-CO-V2 mRNA Vaccines

The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease has no precedent. The many alterations in the vaccine mRNA hide the mRNA from cellular defenses and promote a longer biological half-life and high production of spike protein. However, the immune response to the vaccine is very different from that to a SARS-CoV-2 infection. In this paper, we present evidence that vaccination induces a profound impairment in type I interferon signaling, which has diverse adverse consequences to human health. Immune cells that have taken up the vaccine nanoparticles release into circulation large numbers of exosomes containing spike protein along with critical microRNAs that induce a signaling response in recipient cells at distant sites. We also identify potential profound disturbances in regulatory control of protein synthesis and cancer surveillance. These disturbances potentially have a causal link to neurodegenerative disease, myocarditis, immune thrombocytopenia, Bell’s palsy, liver disease, impaired adaptive immunity, impaired DNA damage response and tumorigenesis. We show evidence from the VAERS database supporting our hypothesis. We believe a comprehensive risk/benefit assessment of the mRNA vaccines questions them as positive contributors to public health.

  • + +

Autoimmune Disease

A Case Series and Literature Review of the Association of COVID-19 Vaccination with Autoimmune Diseases: Causality or Chance?

Immune mediated events timely associated with COVID-19 vaccine

Bell’s Palsy/Nerve Palsy

Acute Abducens Nerve Palsy following Pfizer

34yoF with Bell’s Palsy 2 Days after Moderna

37yoM with Bell’s Palsy after Pfizer

61yoM with Bell’s Palsy after Each Dose of Pfizer

Rate of Bell’s Palsy following mRNA Vaccination is 2-3x Higher than Expected


Rapid Progression of T-Cell Lymphoma following Pfizer Booster

13 Cases of Cervical Lymphadenopathy

Review of 24 Cases of Lymphadenopathy and their Ultrasound Findings in the US

Higher Hypermetabolic Lymphadenopathy Detection on PET/CT and Impact on Oncologic Management

163 Cases of Axillary Adenopathy Following Pfizer

Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report

Post vaccination lymphadenopathy: report of cytological findings from fine needle aspiration biopsy

denopathy after vaccination in a woman with breast cancer

Fine needle aspiration in a vaccine associated lymphadenopathy

Hypermetabolic lymphadenopathy following Pfizer, incidence assessed by FDG PET-CT and revelance to study interpretation, a review of 728 vaccinated patients



An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccination

A Rare Case of Coronavirus Disease 2019 Vaccine-Associated Cerebral Venous Sinus Thrombosis Treated with Mechanical Thrombectomy

Acute Myocardial Infarction, Coronal Arteritis and Myocarditis after BNT162b2 mRNA Vaccination against Covid-19

Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings

Myocarditis after Covid-19 mRNA Vaccination

Unprovoked Submassive Saddle Pulmonary Embolism in an Adult Male After Pfizer COVID-19 Vaccination

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

Autopsy-based Histopathological Characterization of Myocarditis after anti-SARS-CoV-2-Vaccination

COVID-19 mRNA Vaccine-induced Pneumonitis

Eosinophilic Pneumonia Associated to SARS-CoV-2 Vaccine

Perimyocarditis in Adolescents after Pfizer Vaccine

COVID-19 Vaccine-induced Myocarditis: Case Report with Literature Review

Fulminant Myocarditis Requiring ECMO in a 60yoF following 2nd dose Pfizer

Pericarditis following mRNA Vaccination

Myocarditis in a 16yo, Late Gadolinium Enhancement

3 Cases of Cardiac Manifestation following Pfizer

Myocarditis with BNT162b2 Messenger RNA COVID-19 Vaccine in a Series of Children

Cardiac Arrhythmia after COVID-19 Vaccination versus Non–COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data

Ad26.COV2.S Vaccine-Induced Thrombocytopenia Leading to Dural Sinus Thrombosis and Intracranial Hemorrhage Requiring Hemicraniectomy: A Case Report and Systematic Review

PE, TIA, and thrombocytopenia after J&J

Superior ophthalmic Vein Thrombosis and Thrombocytopenia following AstraZeneca

DVT and PE and positive HIT panel following mRNA Vaccine

3 patients with venous thromboembolism following mRNA vaccination

Thrombosis with Thrombocytopenia following Moderna

34yoF with vaccine induced thrombotic thrombocytopenia following Moderna

Case report: vaccine-induced immune thrombotic thrombocytopenia in a pancreatic cancer patient after mRNA vaccination

Case study of Thrombosis and Thrombocytopenia following AstraZeneca

Eltromopag for refractory vaccine-induced immune thrombotic thrombocytopenia in a 64yoF following AstraZeneca vaccination

Acquired TTP following Pfizer

Denovo iTTP episode in a 38yoF following Pfizer

5 cases of prothrombotic immune thrombocytopenia after AstraZeneca

Review of 50 cases of thrombocytopenia following Astrazeneca, Pfizer, Moderna

Thrombotic Thrombocytopenia after AstraZeneca: Autopsy findings

3 cases of adolescents with Pfizer induced TTP

Fatal ICH due to Thrombotic Thrombocytopenia following AstraZeneca

Possible risk of thrombotic events following AstraZeneca in women receiving estrogen

Blood clots and bleeding events following Pfizer and AstraZeneca: an analysis of European data

Venous thromboembolism, thrombocytopenia, and bleeding after vaccination with AstraZeneca in Denmark and Norway: a population based cohort study

Association of AstraZeneca and Pfizer with major venous, arterial, or thrombocytopenic events: a population based cohort study of 46 million adults in England

Arterial thrombosis following 1st dose AstraZeneca: a case series

Late Onset VITT with cerebral venous sinus thrombosis

Confusion and abdominal pain due to VITT following vaccination

Avoidance of vaccine for thrombocytopenic patients and/or myelodysplastic patients or vaccinate and keep them under strict controls – Fatal thromboembolism in a patient with preexisting thrombocytopenia following AstraZeneca

Malignant CVA due to VITT following AstraZeneca

Anti-platelet factor 4 IgG levels in VITT: persistent positivity through 7 months

Thrombosis patterns and clinical outcome of VITT: a systematic review and meta-analysis

Second dose VITT: rare but real

Mechanisms of immunothrombosis in VITT compared to natural COVID infection

3 cases of immune thrombocytopenia following AstraZeneca in Thailand


Persisting, unilateral tinnitus after mRNA vaccine,_unilateral_tinnitus_22_days_after.175.aspx

3 cases of Tinnitus following mRNA vaccination

COVID-vaccine associated tinnitus: a review of VAERS

Vestibular neuritis in a 54yoM following Pfizer

Bilateral Vocal Fold Paralysis after 3rd dose Pfizer requiring intubation and tracheostomy

Ulcers of bilateral palate mucosa following Moderna in a 58yoF


5 Cases of Adrenal Crisis following AstraZeneca


Covid-19 vaccination BNT162b2 temporarily impairs semen concentration and total motile count among semen donors

Guillane-Barre Syndrome

Sensory Ataxic GBS with Immunoglobulin G Anti-GM1 Antibodies following Pfizer


Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2Vaccination in Patient with Multiple Myeloma

Rituximab-induced Acute Lympholysis and Pancytopenia after Moderna in a 71yoM with b-cell Lymphoplasmacytic Lymphoma

Successful Venous Thromboprophylaxis in a Patient with AstraZeneca-induced VITT

Coagulopathies after vaccination against SARS-COV-2 may be derived from a combo of spike protein and adenovirus vector-triggered signaling pathways

Arterial Thrombosis in an Unusual Site (ulnar artery) in a 68yoM following 3rd dose of Moderna

Changes in Blood Viscosity after COVID-19 vaccination

Coagulopathies after vaccination against SARS-COV-2 may be derived from a combo of spike protein and adenovirus vector-triggered signaling pathways

Vaccine induced thrombocytopenia and thrombosis: venous endotheliopathy leading to venous combined micro-macrothrombosis

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia

Safety warning for AstraZeneca in patients with sickle cell disease

Acquired Hemophilia A following COVID-19 Vaccination—The Importance of Prompt

Diagnosis: A Case Report


2 Cases of Löfgren’s Syndrome following AstraZeneca and Moderna Vaccination

Cubital Tunnel Syndrome Temporally following Moderna in a 28yoF

New-onset Polymyalgia Rheumatica in a 80yoF following Pfizer

50yoM with HSP including IgA Leukocytoclastic Vasculitis on Skin Biopsy following Pfizer

Rash, Arthritis, Swelling, Muscle weakness following AstraZeneca

Polyarthralgia and Myalgia Syndrome after AstraZeneca

Remitting seronegative symmetrical synovitis with pitting edema following Pfizer

Pheochromocytoma Crisis following J&J vaccination

Chronic Inflammatory Demyelinating Polyneuropathy after AstraZeneca vaccination:


New onset Evans Syndrome associated with systemic lupus erythematosus after Pfizer vaccination

Hemophagocytic lymphohistiocytosis (HLH) in a 14yoF requiring VA ECMO

3 cases of HLH following AstraZeneca

Multiple Sclerosis

New onset MS in a 32yoF patient following Pfizer

Multisystem Inflammation

Multisystem Inflammatory Syndrome after Covid 19 Vaccination

Beware of the ambiguous enemy of multisystem inflammatory syndrome in adult (MIS‐A) following Covid‐19 infection or vaccination

Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?

Multisystem Inflammatory-like Syndrome in a Child Following COVID-19 mRNA Vaccination

Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection

Multi inflammatory syndrome in a 16-year-old male following first dose of m-RNA COVID-19 vaccination

Multisystem inflammatory syndrome in an adult following Pfizer (MIS-V)

MIS in 2 adults with short interval between COVID-19 infection and subsequent vaccination

Two cases of MIS-V: 15yoF and 17yoF

MIS resulting in reversible autoimmune cardiomyopathy in a 25yoM following 3rd dose of COVID vaccination

MIS-V with erythema multiforme-like rash in a 62yoM following Pfizer

Multisystem inflammatory syndrome in an adult following Pfizer (MIS-V)

MIS-V in a 22yoF following Pfizer

Multisystem inflammatory syndrome in a 12yo male following Pfizer

Multisystem inflammatory Syndrome in a 12 year old boy after Pfizer

MIS in a 12yoM following Pfizer

Myasthenia Gravis

Fatal Myasthenic Crisis in a 55yoM following AstraZeneca

New onset Myasthenia Gravis in 82yoM following Pfizer

Nervous System

1 case HSV Meningitis following Pfizer

Neuromyelitis Optic in a Healthy Female following Moderna

Neuromyelitis Optica Spectrum Disorder (NMOSD)

Optic Neuropathy after Pfizer and Astrazeneca: a report of 2 cases

Bilateral Optic Neuritis after AstraZeneca

Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data


Rhabdomyolysis after Moderna


New Onset Mainly Guttate Psoriasis after Pfizer

Pustuluar Psoriasis following AstraZeneca

Parkinson’s Disease

COVID-19 Vaccine Associated Parkinson’s Disease, A Prion Disease Signal in the UK Yellow Card Adverse Event Database


First Episode Psychosis Following COVID-19 Vaccination: a Case Report

Retinal/Ocular Events

Retinal Vascular Events after mRNA Vaccination

Central Retinal Vein Occlusion

Combined Retinal Artery and Vein Occlusion after mRNA Vaccination

Acute Retinal Necrosis after mRNA Vaccination

Branch Retinal Vein Occlusion after mRNA Vaccination

Corneal graft rejection after Vaccination

7 Cases of Corneal Graft Rejection after Vaccination

Corneal Graft Rejection Associated with mRNA Vaccines

Corneal Graft Rejection after mRNA Vaccination

Corneal Transplant and DMEK Rejection after mRNA Vaccination

Corneal Rejection may Occur Soon after either Dose of mRNA Vaccine

Patient Diagnosed with Acute Corneal Rejection Due to mRNA Vaccination

Large Series of Patients with Retinal Vein Occlusion following COVID-a9 Vaccination

Possible Sight-threatening Ocular Thrombotic Conditions after COVID-19 Vaccination

Retinal Veinous Occlusion Increase Post mRNA Vaccination in the Past Year

Retinal Detachment in a Healthy Young Woman after COVID-19 Vaccination

Acute Macular Neuroretinopathy following COVID-19 Vaccination

Central Serous Chorioretinopathy following Pfizer (38yoM military physician)

Serous Chorioretinopathy

Acute Central Serous Retinopathy

Bilateral Panuveitis Mimicking Vogt-Koyanagi-Harada Disease


42 Cases of Uveitis and Other Ocular Complications

Reduction of Visual Acuity


Booster Shots Adversely Affect Immune Response

2 Cases Herpes Zoster Ophthalmic following Pfizer

Persistent Varicella Zoster Virus Infection following mRNA COVID-19 Vaccination was Associated with the Presence of Encoded Spike Protein in the Lesion

Herpes Zoster Ophthalmicus in 2 Women after Pfizer–BioNTech (BNT162b2) Vaccine

2 cases (80yoF, 69yoF) of Herpes Ophthalmicus following Pfizer

10 Cases of Herpes Zoster following Covid Vaccination

2 cases of herpes zoster in healthy young adults following vaccination

52 Cases Varicella Zoster Reactivation and mRNA Vaccines as a Trigger

A Case of varicella-zoster Virus after Pfizer with No Pre-existing Conditions

Skin Infections

CMV and Pericarditis in Temporal Association with mRNA Vaccines

1 case HSV Meningitis following Pfizer

Erythema Nodosum

Alopecia Areata

Cutaneous and allergic reactions

Sweet Syndrome with Vasculitis

Sweet Syndrome following SARS CO-V2 Vaccination

Pemphigus vulgaris after COVID-19 vaccination: one new onset and two cases with severe


Spontaneous urticaria after Pfizer vaccine

Pityriasis-rosea like eruption post-vaccination in a young male

35yoM with Pityriasis rosea-like eruption after Pfizer

66yoM with Pityriasis rosea after Pfizer

Pityriasis rubra pilaris following Astra Zeneca

Lichenoid drug eruption following Pfizer

3 cases of new onset acral hand lesions following mRNA vaccine

Patients with eczematous cutaneous reactions following Pfizer

Exacerbation of Hailey-Hailey Disease following mRNA Vaccination

Onset lichen planus following Pfizer

46yoM with lichen planus eruption following AstraZeneca: a case report and review of


Purpura annularis telangiectodes following Pfizer

Flagellate Purpura following AstraZeneca

Symmetrical drug related intertriginous and flexural exanthema like eruption following


Palms and Soles Itchiness following Pfizer

Morphea (70yoF) after AstraZeneca and a second patient after COVID-19Infection

Acral hemorrhage after second dose of vaccination

Facial Pustular Neutrophilic Eruption following mRNA Vaccine

Acute generalized exanthematous pustulosis induced by Moderna

A flare up of pre-existing erythema multiforme following Pfizer:

Atypical erythema multiforme related to Pfizer vaccine

Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination

Bullous pemphigoid triggered by covid-19 vaccine (Pfizer): rapid resolution with corticosteroid therapy

Bullous Fixed Drug Eruption following AstraZeneca

Bullous eruption following Pfizer

Bullous Drug Eruption Rash following Moderna

Bullous pemphigoid associated with covid-19 vaccines: an Italian multicentre study

Bullous Drug Eruption Rash following Moderna

Bullous eruption following Pfizer

Bullous Fixed Drug Eruption following AstraZeneca

Bullous pemphigoid triggered by covid-19 vaccine (Pfizer): rapid resolution with corticosteroid therapy

Atypical erythema multiforme related to Pfizer vaccine

A flare up of pre-existing erythema multiforme following Pfizer

Soft Tissue Filler Inflammatory Reaction after vaccination

Clinical and pathologic correlation of cutaneous covid-19 vaccine reactions including V-REPP: a registry-based study

New onset leukocytoclastic vasculitis following COVID-19 vaccination

Cutaneous adverse events related to COVID-19 vaccines: a cross-sectional questionnaire-based study of 867 patients

Soft Tissue Filler Inflammatory Reaction after vaccination

Breast Implant seroma after mRNA vaccine

Breast Implant Capsular Contracture following Moderna vaccination

2 cases of Vitiligo triggered by COVID-19 vaccination

Bacillus Calmette-Guerin scar erythema in a 14yoF post Pfizer vaccination

Generalized papulovesicular eruption as a side effect of Pfizer vaccine

Leukocytoclastic vasculitis after Pfizer

Cutaneous vasculitis following AstraZeneca

Leukocytoclastic vasculitis after exposure to AstraZeneca vaccine

Sweet-like syndrome and multiple covid-arm syndrome following covid-19 vaccine: specific patterns in a series of 192 patients

Possible case of mRNA vaccine induced small vessel vasculitis

Cutaneous lymphocytic vasculitis following mRNA vaccine

Relapse of microscopic polyangiitis after Pfizer vaccination: a case report

2 cases of skin color discoloration following mRNA vaccination

Moderna Vaccine Induced Skin Rash

from this link


The Time for Silence is Over

A unified pushback against the globalist agenda

It’s finally here, the Global Walkout begins September 4th at 8pm London time and continue every weeks. Next step 4th June 2023.

One step at a time, hand in hand, we are walking out from the globalist society they are trying to enslave us into

ANYONE can participate
ANYWHERE in the world

JOIN or read about it here –

The third step is to unsubscribe from all mainstream media outlets. Delete the apps from your phone, laptop, and tablet and unfollow all of their social media and YouTube channels. Try to avoid mainstream media for at least one week, even if the headline is intriguing.

In the same time why not removing all the big tech tracking/spying/social credit system around you: (Youtube, Facebook, Instagram, Twitter, Tik Tok, Google, Apple, Microsoft, Whatsapp, Zoom, Linkedln, Snapchat, Tumblr, Pinterest, Reddit, Myspace, etc.)

The fourth step of the global walkout is to move as many accounts as you can to a union or local bank.

If you like our work please consider to donate :


If you are looking for solutions (lawyer, form, gathering, action, antidote, treatments, maybe this could help you:

If you want to fight back better:

Find the others:

Spike Protein Protocol 

Glutathione (most important for body detoxification) or better
NAC = N-Acetyl-Cysteine 600-750mg (causes the body to produce glutathione itself)
Astaxantin 5mg (also improves vision)
vitamin D3
Milk thistle (also liver and stomach protection)
Melatonin 1mg to 10mg (against 5G)
Alternatively CDS/CDL and zeolite

Dr. Zelenko’s Protocol contains Ivermectin, Hydroxychloroquine (HCQ), Zinc, Vitamin D3, and Quercetin.

How to find the truth :

Search engine:,, Searx (choose the server that you want) or

Facebook style: or


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: